LipoCure Competitors and Similar CompaniesClear all
LipoCure's competitors and similar companies include Dare Bioscience and NexImmune.
 LipoCure LipoCure is a company developing therapeutics utilizing its proprietary liposomal delivery technology and nano-technology. |  Dare Bioscience Dare Bioscience (formerly Cerulean Pharma) develops nanotechnology-based therapeutics for treating oncology, cardiovascular, autoimmune and inflammatory diseases. |  NexImmune NexImmune is a biopharmaceutical company developing immunotherapy products based on the Artificial Immune Modulation nanotechnology platform. | |
Founding Date | Founding Date 2009 | Founding Date 2006 | Founding Date 2011 |
Type | Type Private | Type Public | Type Public |
Tags | |||
Locations | Locations Jerusalem, IL HQ | Locations San Diego, US HQ | Locations Gaithersburg, US HQ |
Employees | Employees 811% decrease | Employees 980% increase | Employees 5032% decrease |
Valuation ($) | Valuation ($) N/A | Valuation ($) 33.8 m | Valuation ($) 372.4 k |
Financial | |||
Net income | Net income N/A | Net income ($13.4m) (FY, 2025) | Net income ($32.3m) (FY, 2023) |
Funding | |||
Total funding raised | Total funding raised N/A | Total funding raised $ 115.7m | Total funding raised $ 33.8m |
For sources of this data, please see the company profile
View Company Profiles
Dare Bioscience
HQ
San Diego, US
Employees
9
Dare Bioscience (formerly Cerulean Pharma) develops nanotechnology-based therapeutics for treating oncology, cardiovascular, autoimmune and inflammatory diseases.
View companyNexImmune
HQ
Gaithersburg, US
Employees
50↓ 32% decrease
NexImmune is a biopharmaceutical company developing immunotherapy products based on the Artificial Immune Modulation nanotechnology platform.
View company